Guzman MG, Kouri G, 2002. Dengue: an update. Lancet Infect Dis 2 :33–42.
Sabin AB, 1952. Research on dengue during World War II. Am J Trop Med Hyg 1 :30–50.
Nimmannitya S, Thisyakorn U, Hemsrichart V, 1987. Dengue haemorrhagic fever with unusual manifestations. Southeast Asian J Trop Med Public Health 18 :398–406.
Guzman MG, Kouri G, 2003. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 27 :1–13.
Valdes L, Guzman MG, Kouri G, Delgado J, Carbonell I, Cabrera MV, Rosario D, Vazquez S, 1999. Epidemiology of dengue and hemorrhagic dengue in Santiago, Cuba 1997. Rev Panam Salud Publica 6 :16–25.
Guzman MG, Alvarez M, Rodriguez R, Rosario D, Vazquez S, Vald SL, Cabrera MV, Kouri G, 1999. Fatal dengue hemorrhagic fever in Cuba, 1997. Int J Infect Dis 3 :130–135.
Kouri GP, Guzman MG, Bravo JR, 1987. Why dengue haemorrhagic fever in Cuba? 2. An integral analysis. Trans R Soc Trop Med Hyg 81 :821–823.
Bravo JR, Guzman MG, Kouri GP, 1987. Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 81 :816–820.
Harris E, Videa E, Perez L, Sandoval E, Tellez Y, Perez ML, Cuadra R, Rocha J, Idiaquez W, Alonso RE, Delgado MA, Campo LA, Acevedo F, Gonzalez A, Amador JJ, Balmaseda A, 2000. Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua. Am J Trop Med Hyg 63 :5–11.
Burke DS, Nisalak A, Johnson DE, Scott RM, 1988. A prospective study of dengue infections in Bangkok. Am J Trop Med Hyg 38 :172–180.
Halstead SB, 1988. Pathogenesis of dengue: challenges to molecular biology. Science 239 :476–481.
Guzman MG, Kouri G, Martinez E, Bravo J, Riveron R, Soler M, Vazquez S, Morier L, 1987. Clinical and serologic study of Cuban children with dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). Bull Pan Am Health Organ 21 :270–279.
Guzman MG, Kouri G, Valdes L, Bravo J, Alvarez M, Vazques S, Delgado I, Halstead SB, 2000. Epidemiologic studies on Dengue in Santiago de Cuba, 1997. Am J Epidemiol 152 :793–799.
Pelaez O, Guzman MG, Kouri G, Perez R, San Martin JL, Vazquez S, Rosario D, Mora R, Quintana I, Bisset J, Cancio R, Masa AM, Castro O, Gonzalez D, Avila LC, Rodriguez R, Alvarez M, Pelegrino JL, Bernardo L, Prado I, 2004. Dengue 3 epidemic, Havana, 2001. Emerg Infect Dis 10 :719–722.
Guzman MG, Kouri GP, Bravo J, Soler M, Vazquez S, Morier L, 1990. Dengue hemorrhagic fever in Cuba, 1981: a retrospective seroepidemiologic study. Am J Trop Med Hyg 42 :179–184.
PAHO, 1994. Dengue and Dengue Hemorrhagic Fever in the Americas: Guidelines for Prevention and Control. Scientific publication no. 548. Washington, DC: Pan American Health Organization.
Vazquez S, Saenz E, Huelva G, Gonzalez A, Kouri G, Guzman M, 1998. Deteccion de IgM contra el virus del dengue en sangre entera absorbida en papel de filtro. Rev Panam Salud Publica 3 :174–178.
Vazquez S, Bravo JR, Perez AB, Guzman MG, 1997. Inhibiting ELISA: its utility for classifying a case of dengue. Rev Cubana Med Trop 49 :108–112.
Morens DM, Halstead SB, Repik PM, Putvatana R, Raybourne N, 1985. Simplified plaque reduction neutralization assay for dengue viruses by semimicro methods in BHK-21 cells: comparison of the BHK suspension test with standard plaque reduction neutralization. J Clin Microbiol 22 :250–254.
M.Alvarez M, Rodriquez-Roche R, Bernardo L, Morier L, Guzman MG, 2005. Improved dengue virus plaque formation on BHK 21 and LLCMK2 cells: evaluation of some factors. Dengue Bulletin 29 :49–57.
Russell PK, Nisalak A, Sukhavachana P, Vivona S, 1967. A plaque reduction test for dengue virus neutralizing antibodies. J Immunol 99 :285–290.
Guzman MG, Kouri G, Bravo J, Soler M, Martinez E, 1991. Sequential infection as risk factor for dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) during the 1981 dengue hemorrhagic Cuban epidemic. Mem Inst Oswaldo Cruz 86 :367.
Past two years | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 0 | 0 | 0 |
Full Text Views | 435 | 220 | 3 |
PDF Downloads | 130 | 61 | 3 |
A dengue epidemic caused by dengue virus 3 (DENV-3) occurred in Cuba in 2001–2002. It included cases of dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS). We report neutralizing antibody studies on sera from 54 of 78 DHF/DSS patients that provide evidence of infections occurring in the sequence DENV-1 followed by DENV-3. No sera showed infection in the sequence DENV-2 followed by DENV-3. Some sera showed a pattern of infection in the sequence DENV-1 followed by DENV-2 and then DENV-3. However definitive categorization of a tertiary infection was not possible because of broadly reactive antibodies, which could have been raised by infections in the sequence DENV-1 then DENV-3.